NHC vs PACS

Head-to-Head Stock Analysis & Investment Rating

Last Updated: Sep 11, 2026

NHC

57.6
AI Score
VS
PACS Wins

PACS

67.7
AI Score

Investment Advisor Scores

NHC

Sep 11, 2026
58score
Recommendation
HOLD

PACS

Sep 11, 2026
68score
Recommendation
BUY

AI Analyst Insights

Detailed Metrics Comparison

Metric NHC PACS Winner
Forward P/E 9.8912 16.5017 NHC
PEG Ratio 0.8241 1.1007 NHC
Revenue Growth 8.8% 9.1% PACS
Earnings Growth 67.1% 51.6% NHC
Tradestie Score 57.6/100 67.7/100 PACS
Profit Margin 9.0% 4.9% NHC
Beta 1.00 1.00 Tie
Implied Volatility N/A N/A Tie
AI Recommendation HOLD BUY PACS

Relative Price Performance (Last 90 Days)

NHC 1M: +1.3% · 3M: +14.6% PACS 1M: -1.6% · 3M: +28.8%

Current Technical Phase

NHC

Markup
Hold / add on dips

Price above SMA50, rising 50-day trend (5.2% over 20 days), RSI 52

RSI (14): 52.2 · Price: $224.47

PACS

Neutral
Hold

Mixed signals - no dominant trend phase, RSI 54

RSI (14): 54.5 · Price: $44.76

Fundamentals Snapshot

Metric NHC PACS
Market Cap
Forward P/E 9.9 16.5
Trailing P/E 25.5 26.1
Revenue (TTM)
Revenue Growth 0.1% 0.1%
Gross Margin 0.4% 0.2%
Operating Margin 0.1% 0.1%
EPS 8.82 1.72
Dividend Yield 0.01%

Frequently Asked Questions

Based on our detailed analysis, PACS is currently the stronger investment candidate, winning 3 of the key financial metrics based on our comprehensive scoring model.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.